Back to Search
PETER WEIDEN, MD
MD
Psychiatry Physician
NPI: 1386754125Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
150916(NY)
Research & Publications (20)
Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
PMID 18334908·J Clin Psychopharmacol·2008
8-other
Long-term changes in weight and plasma lipids during maintenance treatment with ziprasidone.
PMID 17637612·Neuropsychopharmacology·2008
3-trial
Understanding and treating "first-episode" schizophrenia.
PMID 17720033·Psychiatr Clin North Am·2007
6-review
Translating the psychopharmacology of antipsychotics to individualized treatment for severe mental illness: a Roadmap.
PMID 17650057·J Clin Psychiatry·2007
6-review
Understanding and addressing adherence issues in schizophrenia: from theory to practice.
PMID 18284273·J Clin Psychiatry·2007
6-review
Implicit versus explicit attitudes toward psychiatric medication: Implications for insight and treatment adherence.
PMID 19410431·Schizophr Res·2009
8-other
Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol.
PMID 19419595·Int J Neuropsychopharmacol·2009
4-observational
Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia.
PMID 19292973·J Clin Psychiatry·2009
8-other
Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.
PMID 18312044·J Clin Psychiatry·2008
4-observational
Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
PMID 18334909·J Clin Psychopharmacol·2008
3-trial
Phase 2 study of intraperitoneal topotecan as consolidation chemotherapy in ovarian and primary peritoneal carcinoma.
PMID 18521923·Cancer·2008
3-trial
Cognitive-behavioral therapy for medication-resistant schizophrenia: a review.
PMID 18212600·J Psychiatr Pract·2008
6-review
Antipsychotic-induced movement disorders - forgotten but not gone.
PMID 18479315·Acta Psychiatr Scand·2008
8-other
Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia.
PMID 17539698·J Clin Psychiatry·2007
6-review
Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.
PMID 17606657·Am J Psychiatry·2007
4-observational
Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications.
PMID 17650055·J Clin Psychiatry·2007
6-review
Distress with medication side effects among persons with severe mental illness.
PMID 17653845·Adm Policy Ment Health·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 912 S WOOD ST, UIC PSYCHIATRY MC913
CHICAGO, IL 60612 - Phone
- (312) 996-6557
Quick Facts
- NPI
- 1386754125
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile